Stockreport

Acceleron Announces Oral Presentation of PULSAR Phase 2 Trial Results in Virtual American Thoracic Society 2020 Conference Session on June 24, 2020

Acceleron Pharma Inc.  (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations
PDF Acceleron to host an investor and analyst webcast and conference call following the virtual ATS 2020 presentation on June 24th CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acc [Read more]